J Knee Surg 2018; 31(03): 270-276
DOI: 10.1055/s-0037-1603333
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Tranexamic Acid Effectively Reduces Blood Loss and Transfusion Rates during Simultaneous Bilateral Total Knee Arthroplasty

Hernan A. Prieto
1   Department of Orthopaedics and Rehabilitation, College of Medicine, University of Florida, Gainesville, Florida
,
Heather K. Vincent
1   Department of Orthopaedics and Rehabilitation, College of Medicine, University of Florida, Gainesville, Florida
,
Justin T. Deen
1   Department of Orthopaedics and Rehabilitation, College of Medicine, University of Florida, Gainesville, Florida
,
Dane A. Iams
1   Department of Orthopaedics and Rehabilitation, College of Medicine, University of Florida, Gainesville, Florida
,
Hari K. Parvataneni
1   Department of Orthopaedics and Rehabilitation, College of Medicine, University of Florida, Gainesville, Florida
› Author Affiliations
Funding None.
Further Information

Publication History

14 October 2016

31 March 2017

Publication Date:
15 May 2017 (online)

Abstract

Tranexamic acid (TXA) can reduce blood loss and decrease transfusion rates after total knee arthroplasty (TKA). The purpose of our study was to evaluate the efficacy of TXA in a homogenous, consecutive cohort of patients undergoing simultaneous bilateral primary TKA. This was a retrospective study of 50 consecutive patients who underwent bilateral simultaneous primary TKA between 2011 and 2015. Of these, 20 patients received TXA and 30 patients did not receive TXA and served as the control group. Primary outcome measurements were intraoperative estimated blood loss, hemoglobin (Hb) and Hematocrit (Hct) levels on postoperative day (POD) 1 and POD2, and blood transfusion rates. Secondary outcomes included length of stay (LOS), knee flexion/extension range of motion (ROM), and postoperative complications. There was no difference between groups for preoperative Hb and Hct (all p > 0.05). The TXA group demonstrate higher Hb levels at POD1 (11.7 in TXA vs. 10.4 controls; p < 0.001) and POD2 (10.5 in TXA vs. 9.6 controls; p < 0.001), as well as higher Hct levels at POD1 (35.6 in TXA vs. 32.1 controls; p < 0.001) and POD2 (31.9 in TXA vs. 29.3 controls; p < 0.001). There was less percentage variation in Hb levels in the TXA group from preoperative to POD1 (17.7% in TXA vs. 25.7% controls; p < 0.0001) and POD2 (26.1% TXA vs. 31.8% controls; p = 0.019). Similarly, less percentage variation in Hct levels in the TXA group from presurgery to POD1 (17.0% TXA vs. 25.7% controls; p < 0.0001) and POD2 (25.0% TXA vs. 31.3% controls; p = 0.005). A total of 23.3% of patients in the control group required transfusions compared with no patients in the TXA (p = 0.044). There were no differences in LOS, knee ROM, or number of complications. No thromboembolic events occurred. TXA in bilateral simultaneous TKA effectively reduces blood loss, maintains postoperative Hb and Hct levels, and significantly decreases blood transfusion rates. The level of evidence is level III (therapeutic study).

 
  • References

  • 1 Centers for Disease Control and Prevention. National Hospital Discharge Survey: 2010 table, procedures by selected patient characteristics. 2013
  • 2 Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am 2007; 89 (04) 780-785
  • 3 Parvizi J, Chaudhry S, Rasouli MR. , et al. Who needs autologous blood donation in joint replacement?. J Knee Surg 2011; 24 (01) 25-31
  • 4 Bierbaum BE, Callaghan JJ, Galante JO, Rubash HE, Tooms RE, Welch RB. An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg Am 1999; 81 (01) 2-10
  • 5 Ritter MA, Harty LD, Davis KE, Meding JB, Berend M. Simultaneous bilateral, staged bilateral, and unilateral total knee arthroplasty. A survival analysis. J Bone Joint Surg Am 2003; 85-A (08) 1532-1537
  • 6 Reuben JD, Meyers SJ, Cox DD, Elliott M, Watson M, Shim SD. Cost comparison between bilateral simultaneous, staged, and unilateral total joint arthroplasty. J Arthroplasty 1998; 13 (02) 172-179
  • 7 Odum SM, Troyer JL, Kelly MP, Dedini RD, Bozic KJ. A cost-utility analysis comparing the cost-effectiveness of simultaneous and staged bilateral total knee arthroplasty. J Bone Joint Surg Am 2013; 95 (16) 1441-1449
  • 8 Bullock DP, Sporer SM, Shirreffs Jr TG. Comparison of simultaneous bilateral with unilateral total knee arthroplasty in terms of perioperative complications. J Bone Joint Surg Am 2003; 85-A (10) 1981-1986
  • 9 Jankiewicz JJ, Sculco TP, Ranawat CS, Behr C, Tarrentino S. One-stage versus 2-stage bilateral total knee arthroplasty. Clin Orthop Relat Res 1994; (309) 94-101
  • 10 Pulido L, Ghanem E, Joshi A, Purtill JJ, Parvizi J. Periprosthetic joint infection: the incidence, timing, and predisposing factors. Clin Orthop Relat Res 2008; 466 (07) 1710-1715
  • 11 Friedman RJ. Limit the bleeding, limit the pain in total hip and knee arthroplasty. Orthopedics 2010; 33 (9, Suppl): 11-13
  • 12 Eubanks JD. Antifibrinolytics in major orthopaedic surgery. J Am Acad Orthop Surg 2010; 18 (03) 132-138
  • 13 Dunn CJ, Goa KL. Tranexamic acid: a review of its use in surgery and other indications. Drugs 1999; 57 (06) 1005-1032
  • 14 Alshryda S, Sarda P, Sukeik M, Nargol A, Blenkinsopp J, Mason JM. Tranexamic acid in total knee replacement: a systematic review and meta-analysis. J Bone Joint Surg Br 2011; 93 (12) 1577-1585
  • 15 Yang Z-G, Chen W-P, Wu L-D. Effectiveness and safety of tranexamic acid in reducing blood loss in total knee arthroplasty: a meta-analysis. J Bone Joint Surg Am 2012; 94 (13) 1153-1159
  • 16 Karam JA, Bloomfield MR, DiIorio TM, Irizarry AM, Sharkey PF. Evaluation of the efficacy and safety of tranexamic acid for reducing blood loss in bilateral total knee arthroplasty. J Arthroplasty 2014; 29 (03) 501-503
  • 17 Bagsby DT, Samujh CA, Vissing JL, Empson JA, Pomeroy DL, Malkani AL. Tranexamic acid decreases incidence of blood transfusion in simultaneous bilateral total knee arthroplasty. J Arthroplasty 2015; 30 (12) 2106-2109
  • 18 MacGillivray RG, Tarabichi SB, Hawari MF, Raoof NT. Tranexamic acid to reduce blood loss after bilateral total knee arthroplasty: a prospective, randomized double blind study. J Arthroplasty 2011; 26 (01) 24-28
  • 19 Kelley TC, Tucker KK, Adams MJ, Dalury DF. Use of tranexamic acid results in decreased blood loss and decreased transfusions in patients undergoing staged bilateral total knee arthroplasty. Transfusion 2014; 54 (01) 26-30
  • 20 Whiting DR, Gillette BP, Duncan C, Smith H, Pagnano MW, Sierra RJ. Preliminary results suggest tranexamic acid is safe and effective in arthroplasty patients with severe comorbidities. Clin Orthop Relat Res 2014; 472 (01) 66-72
  • 21 Benjamin J, Tucker T, Ballesteros P. Is obesity a contraindication to bilateral total knee arthroplasties under one anesthetic?. Clin Orthop Relat Res 2001; (392) 190-195
  • 22 Brotherton SL, Roberson JR, de Andrade JR, Fleming LL. Staged versus simultaneous bilateral total knee replacement. J Arthroplasty 1986; 1 (04) 221-228
  • 23 Cohen RG, Forrest CJ, Benjamin JB. Safety and efficacy of bilateral total knee arthroplasty. J Arthroplasty 1997; 12 (05) 497-502
  • 24 Dennis DA. Debate: bilateral simultaneous total knee arthroplasty. Clin Orthop Relat Res 2004; (428) 82-83
  • 25 Gradillas EL, Volz RG. Bilateral total knee replacement under one anesthetic. Clin Orthop Relat Res 1979; (140) 153-158
  • 26 Ritter MA, Meding JB. Bilateral simultaneous total knee arthroplasty. J Arthroplasty 1987; 2 (03) 185-189
  • 27 Ritter MA. Simultaneous knee replacement is better for the patient. Orthopedics 1998; 21 (04) 415-418 , 418
  • 28 Ritter MA. Bilateral simultaneous TKR: doing what's best for the patient. Orthopedics 2000; 23 (06) 538
  • 29 Ritter MA, Harty LD. Debate: simultaneous bilateral knee replacements: the outcomes justify its use. Clin Orthop Relat Res 2004; (428) 84-86
  • 30 Parvizi J, Sullivan TA, Trousdale RT, Lewallen DG. Thirty-day mortality after total knee arthroplasty. J Bone Joint Surg Am 2001; 83-A (08) 1157-1161
  • 31 Pavone V, Johnson T, Saulog PS, Sculco TP, Bottner F. Perioperative morbidity in bilateral one-stage total knee replacements. Clin Orthop Relat Res 2004; (421) 155-161
  • 32 Ritter M, Mamlin LA, Melfi CA, Katz BP, Freund DA, Arthur DS. Outcome implications for the timing of bilateral total knee arthroplasties. Clin Orthop Relat Res 1997; (345) 99-105
  • 33 Rosenberg AG. True indications for bilateral simultaneous TKR are rare. Orthopedics 2000; 23 (06) 540
  • 34 Restrepo C, Parvizi J, Dietrich T, Einhorn TA. Safety of simultaneous bilateral total knee arthroplasty. A meta-analysis. J Bone Joint Surg Am 2007; 89 (06) 1220-1226
  • 35 Bolognesi MP, Watters TS, Attarian DE, Wellman SS, Setoguchi S. Simultaneous vs staged bilateral total knee arthroplasty among Medicare beneficiaries, 2000-2009. J Arthroplasty 2013; 28 (8, Suppl) 87-91
  • 36 Suleiman LI, Edelstein AI, Thompson RM, Alvi HM, Kwasny MJ, Manning DW. Perioperative outcomes following unilateral versus bilateral total knee arthroplasty. J Arthroplasty 2015; 30 (11) 1927-1930
  • 37 Karaaslan F, Karaoğlu S, Mermerkaya MU, Baktir A. Reducing blood loss in simultaneous bilateral total knee arthroplasty: combined intravenous-intra-articular tranexamic acid administration. A prospective randomized controlled trial. Knee 2015; 22 (02) 131-135